Skip to search formSkip to main contentSkip to account menu

Aromasin

Known as: Aromasil, Aromasine, Aromasin® 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

exemestane
exemestane 25 MG Oral Tablet [Aromasin]exemestane Oral Tablet [Aromasin]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract P1-12-15: Intermittent dosing of aromatase inhibitors (AI) to improve tolerance in post-menopausal women
Clinical rationale: A significant proportion of post-menopausal, patients treated with AI reports side-effects, especially bone… 
2008
2008
Study showing the efficacy of aromasin in metastatic CA breast in postmenopausal women
12023 Background: Aromatase inhibitors have been shown to be better choice for Hormone therapy in Post menopausal receptor… 
2004
2004
Hormonoradiothérapie adjuvante concomitante des cancers du sein : état de l'art
Review
2004
Review
2004
[Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Combining radiation and hormone therapy has become common clinical practice in recent years for locally advanced prostate cancer… 
2000
2000
Exemestane (Aromasin) is active and well tolerated as first-line hormonal therapy (HT) of metastatic breast cancer (MBC) patients (pts): results of a randomized phase II trial
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)